Wedmont Private Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Buy |
1,761
+169
| +11% | +$54.2K | 0.02% | 396 |
|
|
2025
Q1 | $379K | Buy |
1,592
+107
| +7% | +$25.4K | 0.02% | 453 |
|
|
2024
Q4 | $353K | Buy |
1,485
+8
| +0.5% | +$1.9K | 0.02% | 487 |
|
|
2024
Q3 | $394K | Buy |
1,477
+243
| +20% | +$64.8K | 0.02% | 435 |
|
|
2024
Q2 | $321K | Buy |
+1,234
| New | +$321K | 0.02% | 477 |
|
|
2023
Q1 | – | Sell |
-927
| Closed | -$209K | – | 466 |
|
|
2022
Q4 | $209K | Buy |
+927
| New | +$209K | 0.03% | 418 |
|